ArticleCase reports in surgery2026
Malignant Phyllodes Tumor in Adolescent Females: A Report of Three Cases and Review of the Literature.
Article in Case reports in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Malignant Phyllodes Tumor in Adolescent Females: A Report of Three Cases and Review of the Literature.Case reports in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant phyllodes tumors (MPTs) are quite a rare type of mesenchymal breast cancer that can mimic benign lesions such as fibroadenomas histologically and radiologically. They account for less than 1% of all breast cancers, and they usually occur commonly in younger and middle-aged women. We report three cases of MPT with ages ranging between 15 and 20 years from the Eastern region of Uganda that were obtained consecutively at our institution for the period of 3 years (from 2023 to 2025). Case 1 was a 15-year-old female with 2 months history of a left breast mass that was painful, rapidly growing, and associated with ulceration; it was confirmed histologically to be MPT and was treated successfully with ifosfamide 390 mg, doxorubicin 48 mg, and dexamethasone 8 mg. Case 2 was a 19-year-old female with 6-month history of a right breast mass that was associated with pain and tenderness, and the mass was confirmed histologically to be MPT though she died before the initiation of treatment. Case 3 was a 20-year-old female with 3-month history of a left breast mass that was associated with intermittent pains. She also had a positive family history of breast cancer. Her mass in the breast was confirmed histologically to be MPT and she was also treated with ifosfamide 390 mg, doxorubicin 48 mg, and dexamethasone 8 mg. All three cases tested positive for vimentin, but case 2 also showed focally positive SMA, but all of them were triple negative with Ki67 expression ranging from 20% to 35%. MPTs are rare and are more likely to recur, and they tend to have rapid growth and metastasis. Timely and proper management of patients with MPT helps to prevent possibilities of metastasis and improve the prognosis of the patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.